| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥10.24B | ¥10.00B | +2.4% |
| Cost of Sales | ¥7.13B | ¥6.96B | +2.4% |
| Gross Profit | ¥3.11B | ¥3.03B | +2.5% |
| SG&A Expenses | ¥2.73B | ¥2.70B | +1.3% |
| Operating Income | ¥379M | ¥337M | +12.5% |
| Non-operating Income | ¥88M | ¥31M | +181.4% |
| Non-operating Expenses | ¥78M | ¥26M | +198.5% |
| Ordinary Income | ¥389M | ¥343M | +13.4% |
| Profit Before Tax | ¥389M | ¥344M | +13.3% |
| Income Tax Expense | ¥134M | ¥118M | +13.5% |
| Net Income | ¥256M | ¥226M | +13.1% |
| Net Income Attributable to Owners | ¥250M | ¥222M | +12.6% |
| Total Comprehensive Income | ¥320M | ¥209M | +53.1% |
| Interest Expense | ¥3M | ¥3M | -2.7% |
| Basic EPS | ¥80.40 | ¥70.87 | +13.4% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥7.05B | ¥6.64B | +¥412M |
| Cash and Deposits | ¥3.29B | ¥2.94B | +¥348M |
| Accounts Receivable | ¥3.03B | ¥2.89B | +¥132M |
| Inventories | ¥503M | ¥531M | ¥-28M |
| Non-current Assets | ¥9.74B | ¥9.81B | ¥-76M |
| Item | Value |
|---|---|
| Book Value Per Share | ¥3,653.54 |
| Net Profit Margin | 2.4% |
| Gross Profit Margin | 30.4% |
| Current Ratio | 213.3% |
| Quick Ratio | 198.0% |
| Debt-to-Equity Ratio | 0.44x |
| Interest Coverage Ratio | 113.54x |
| Effective Tax Rate | 34.3% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +2.4% |
| Operating Income YoY Change | +12.4% |
| Ordinary Income YoY Change | +13.6% |
| Net Income Attributable to Owners YoY Change | +12.8% |
| Total Comprehensive Income YoY Change | +52.9% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 4.22M shares |
| Treasury Stock | 1.10M shares |
| Average Shares Outstanding | 3.12M shares |
| Book Value Per Share | ¥3,732.04 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥23.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| ClinicalTesting | ¥3.92B | ¥153M |
| DispensingPharmacy | ¥5.77B | ¥404M |
| MedicalDevicesAndMaintenance | ¥840M | ¥2M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥20.69B |
| Operating Income Forecast | ¥775M |
| Ordinary Income Forecast | ¥771M |
| Net Income Attributable to Owners Forecast | ¥505M |
| Basic EPS Forecast | ¥162.13 |
| Dividend Per Share Forecast | ¥23.00 |
| Property, Plant & Equipment | ¥8.78B | ¥8.91B | ¥-123M |
| Intangible Assets | ¥121M | ¥125M | ¥-3M |
| Investment Securities | ¥315M | ¥235M | +¥80M |
| Total Assets | ¥16.79B | ¥16.45B | +¥336M |
| Current Liabilities | ¥3.30B | ¥3.12B | +¥184M |
| Accounts Payable | ¥2.20B | ¥2.15B | +¥42M |
| Short-term Loans | ¥30M | - | - |
| Non-current Liabilities | ¥1.84B | ¥1.94B | ¥-97M |
| Long-term Loans | ¥1.26B | ¥1.33B | ¥-67M |
| Total Liabilities | ¥5.14B | ¥5.06B | +¥87M |
| Total Equity | ¥11.64B | ¥11.39B | +¥249M |
| Capital Stock | ¥983M | ¥983M | ¥0 |
| Capital Surplus | ¥1.02B | ¥1.02B | ¥0 |
| Retained Earnings | ¥10.17B | ¥10.00B | +¥179M |
| Treasury Stock | ¥-947M | ¥-947M | ¥0 |
| Owners' Equity | ¥11.40B | ¥11.15B | +¥245M |
| Working Capital | ¥3.74B | - | - |